Background: Exosome, a type of extracellular vesicles, can associate with A␤ in vitro. Results: Intracerebrally injected exosomes trapped A␤ on surface glycosphingolipids and transported it into microglia in AD mouse brains, resulting in reductions in A␤ pathology. Conclusion: Exogenous exosomes act as potent scavengers for A␤ in mouse brains. Significance: The findings provide a novel therapeutic approach for AD.

Good for winter: The structure–activity relationships of antifreeze glycoproteins (AFGPs) have been characterized by chemical synthesis and conformational analysis. The results revealed that the mode of glycosylation on the threonyl residue in the tripeptide unit is of primary importance in the formation of the specific structure for the antifreeze activity (see picture for the structural requirements of AFGPs).

a b s t r a c tElevated amyloid-b peptide (Ab) in brain contributes to Alzheimer's disease (AD) pathogenesis. We demonstrated the presence of exosome-associated Ab in the cerebrospinal fluid (CSF) of cynomolgus monkeys and APP transgenic mice. The levels of exosome-associated Ab notably decreased in the CSF of aging animals. We also determined that neuronal exosomes, but not glial exosomes, had abundant glycosphingolipids and could capture Ab. Infusion of neuronal exosomes into brains of APP transgenic mice decreased Ab and amyloid depositions, similarly to what reported previously on neuroblastoma-derived exosomes. These findings highlight the role of neuronal exosomes in Ab clearance, and suggest that their downregulation might relate to Ab accumulation and, ultimately, the development of AD pathology.

No abstract

Although many of the frequently used pluripotency biomarkers are glycoconjugates, a glycoconjugate-based exploration of novel cellular biomarkers has proven difficult due to technical difficulties. This study reports a unique approach for the systematic overview of all major classes of oligosaccharides in the cellular glycome. The proposed method enabled mass spectrometry-based structurally intensive analyses, both qualitatively and quantitatively, of cellular N-and O-linked glycans derived from glycoproteins, glycosaminoglycans, and glycosphingolipids, as well as free oligosaccharides of human embryonic stem cells (hESCs), induced pluripotent stem cells (hiPSCs), and various human cells derived from normal and carcinoma cells. Cellular total glycomes were found to be highly cell specific, demonstrating their utility as unique cellular descriptors. Structures of glycans of all classes specifically observed in hESCs and hiPSCs tended to be immature in general, suggesting the presence of stem cell-specific glycosylation spectra. The current analysis revealed the high similarity of the total cellular glycome between hESCs and hiPSCs, although it was suggested that hESCs are more homogeneous than hiPSCs from a glycomic standpoint. Notably, this study enabled a priori identification of known pluripotency biomarkers such as SSEA-3, -4, and -5 and Tra-1-60/81, as well as a panel of glycans specifically expressed by hESCs and hiPSCs.omics-based biomarker discovery | stemness | interglycomic correlations | glycoblotting | β-elimination in the presence of pyrazolone